Phibro Animal Health | PAHC - Equity Capital And Reserves


Phibro Animal Health reported $332.36M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Align Technology USD 3.96B 44.68M Sep/2025
ANI Pharmaceuticals USD 540.72M 34.91M Dec/2025
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Henry Schein USD 3.24B 116M Dec/2025
Idexx Laboratories USD 1.61B 44.2M Dec/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Merck USD 51.85B 2.79B Sep/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Pacira USD 693.11M 34.1M Dec/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 1.83B 4.48M Dec/2025
Supernus Pharmaceuticals USD 1.06B 12.05M Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025